Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

With ABBOTINDIA's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 3.38600
forwardPE 38.77595
debtToEquity 4.64600
earningsGrowth 0.27900
revenueGrowth 0.11500
grossMargins 0.45232
operatingMargins 0.25796
trailingEps 665.10000
forwardEps 0.00000

With a current ratio 3.386, ABBOTINDIA demonstrates the ability to service its short-term debt without difficulty. The company's strong cash reserves and current assets ensure that it can meet its liabilities, reflecting financial stability and healthy liquidity.
With positive earnings and revenue growth, Abbott India Limited is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
Positive gross and operating margins for ABBOTINDIA suggest that the company is operating profitably. These margins highlight ABBOTINDIA's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

Abbott India Limited's price projections have been gradually revised upward, reflecting increased confidence in the company's future performance. This trend suggests analysts expect Abbott India Limited to achieve greater success in the coming periods.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


ABBOTINDIA has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view ABBOTINDIA as a stable option to park their money and potentially benefit from the company's continued growth and profitability.